Claudius Conrad, MD, PhD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Claudius Conrad MD, PhD, FACS, FSSO, is a world-renowned surgeon, researcher and sought-after expert in minimally invasive procedures to treat liver, pancreatic and biliary tract cancers. With training at Harvard Medical School and other global centers of expertise, he specializes in cutting-edge techniques and therapies to treat cases other surgical oncologists won’t take on.

Publications

  • Published 5/6/2025

    Cheah DS, Tsai K, Kawano F, Kemprecos HJ, Salirrosas O, Tigranyan A, Cohen MS, Polites G, Kutlu OC, Mise Y, Saiura A, Conrad C. Correction: Are More Young, Western Patients Also Developing Hepatocellular Carcinoma? Ann Surg Oncol. 2025 May 06. PMID: 40327193.

    Read at: PubMed

  • Published 4/22/2025

    Cheah DS, Tsai K, Kawano F, Conrad C. Correction: ASO Author Reflections: Should We be Concerned About Early-Onset Hepatocellular Carcinoma? Ann Surg Oncol. 2025 Apr 22. PMID: 40261525.

    Read at: PubMed

  • Published 3/17/2025

    Cheah DS, Tsai K, Kawano F, Conrad C. ASO Author Reflections: Should We be Concerned About Early-Onset Hepatocellular Carcinoma? Ann Surg Oncol. 2025 Jun; 32(6):3946-3947. PMID: 40097796.

    Read at: PubMed

  • Published 3/10/2025

    Cheah DS, Tsai K, Kawano F, Kemprecos HJ, Salirrosas O, Tigranyan A, Cohen MS, Polites G, Kutlu OC, Mise Y, Saiura A, Conrad C. Are More Young, Western Patients Also Developing Hepatocellular Carcinoma? Ann Surg Oncol. 2025 Jun; 32(6):3924-3932. PMID: 40063237.

    Read at: PubMed

  • Published 3/4/2025

    Kawano F, Conrad C. Invited commentary on "Time to unresectable recurrence - time does not pass, it continues". J Gastrointest Surg. 2025 May; 29(5):102007. PMID: 40049508.

    Read at: PubMed

View All 152 Publications:   View Full Profile in BUMC

Websites

View all profiles